Muscle Pharm Corporation (MSLPQ)

[jeff_green]

Believe Pyatt? This from the Q3 conference call transcript:

Jack D. Wallace - Sidoti & Company, LLC
So I guess looking at the guidance that’s implied for the fourth quarter revenue somewhere between $40 million to $50 million. If you assume the high end of that in the 33% gross margin, which is the guidance that’s in the beginning of the year, you come up with operating expenses of $16.5 million, is that a good place to think of operating expenses in the fourth quarter.

Brad J. Pyatt - President and Chief Executive Officer
I think that’s right in the ballpark, absolutely.

Actual Q4 rev? $32m

Actual Q4 expenses $19m

Fact!

Actual loss of -$15m in Q4.